This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hu, M. G. Articles by Wong, D. T. W. Search for Related Content PubMed PubMed Citation Articles by Hu, M. G. Articles by Wong, D. T. W.

Role of p12^CDK2-AP1 in Transforming Growth Factor-ß1-Mediated Growth Suppression

¹ Department of Pathology, and
² Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, Boston Massachusetts;
³ Laboratory of Head and Neck Cancer Research, Dental Research Institute,
⁴ Jonsson Comprehensive Cancer Center, and
⁵ Molecular Biology Institute, University of California at Los Angeles, Los Angeles, California

p12^CDK2-AP1 (p12) is a growth suppressor isolated from normal keratinocytes. Ectopic expression of p12 in squamous carcinoma cells reversed the malignant phenotype of these cells, in part due an ability of p12 to bind to both DNA polymerase /primase and to cyclin-dependent kinase 2 (CDK2), thereby inhibiting their activities. We report in this article that in normal epithelial cells, transforming growth factor ß1 (TGF-ß1) induces p12 expression transcriptionally, which, in turn, mediates the growth inhibitory activity of TGF-ß1. We created inducible p12 antisense HaCaT cell lines [ip12 (-) HaCaT] and showed that selective reduction of cellular p12 resulted in an increase in: (a) CDK2-associated kinase activity; (b) protein retinoblastoma (pRB) phosphorylation; and (c) [³H]thymidine incorporation, and partially reversed TGF-ß1-mediated inhibition of CDK2 kinase activity, pRB phosphorylation, and cell proliferation. Furthermore, we generated p12-deficient mouse oral keratinocytes (MOK^p12-/-) and compared their growth characteristics and response to TGF-ß1 with that of wild-type mouse oral keratinocytes (MOK^WT). Under normal culture conditions, the number of MOK^p12-/- in S phase is 2-fold greater than that of MOK^WT. Concomitantly, fewer cells are in G₂ phase in MOK^p12-/- than that in MOK^WT. Moreover, response to TGF-ß1-mediated growth suppression is compromised in MOK^p12-/- cells. Mechanistic studies showed that MOK^p12-/- have increased CDK2 activity and reduced sensitivity to inhibition by TGF-ß1. Collectively our data suggest that p12 plays a role in TGF-ß1-mediated growth suppression by modulating CDK2 activities and pRB phosphorylation.

This article has been cited by other articles:

				Y. Q. Xiao, C. G. Freire-de-Lima, W. J. Janssen, K. Morimoto, D. Lyu, D. L. Bratton, and P. M. Henson Oxidants Selectively Reverse TGF-{beta} Suppression of Proinflammatory Mediator Production J. Immunol., January 15, 2006; 176(2): 1209 - 1217. [Abstract] [Full Text] [PDF]